Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
T Cell-Intrinsic Function of the Noncanonical NF-κB Pathway in the Regulation of GM-CSF Expression and Experimental Autoimmune Encephalomyelitis Pathogenesis.
18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions.
Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.
Effects of physiotherapy interventions on balance in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials.
FTY720 attenuates excitotoxicity and neuroinflammation.
Memory impairment in multiple sclerosis is due to a core deficit in initial learning.
Remyelination: The True Regeneration of the Central Nervous System.
Averting inflammation by targeting the cytokine environment.
Neuroendocrine Immunoregulation in Multiple Sclerosis.
AMPYRA® two-year safety data presented at 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Multifocal and pattern-reversal visual evoked potentials vs. automated perimetry frequency-doubling technology matrix in optic neuritis.
Pain mechanisms in multiple sclerosis.
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study.
[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms].
Melanocortins as Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives.
Postpartum complicated by transverse myelitis.
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
Dark microglia: A new phenotype predominantly associated with pathological states.
Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability.
Pages
« first
‹ previous
…
237
238
239
240
241
242
243
244
245
…
next ›
last »